"Implications of the Supreme Court's Decision in PLIVA, Inc. v. Mensing: Why Generic and Brand-Name Pharmaceuticals Must Be Treated Equally Under the Federal Food, Drug, and Cosmetic Act,"
Marquette Elder's Advisor: Vol. 15
, Article 5.
Available at: http://scholarship.law.marquette.edu/elders/vol15/iss1/5